Published in Radiat Environ Biophys on April 10, 2003
On an evaluation of external dose values in the Techa River Dosimetry System (TRDS) 2000. Radiat Environ Biophys (2003) 0.97
Concentrations of 90Sr in the tooth tissues 60 years after intake: results of TL measurements and applications for Techa River dosimetry. Radiat Environ Biophys (2013) 0.89
External radiation exposure of residents living close to the Mayak facility: main sources, dose estimates, and comparison with earlier assessments. Radiat Environ Biophys (2004) 0.86
Evaluation of external exposures of the population of Ozyorsk, Russia, with luminescence measurements of bricks. Radiat Environ Biophys (2009) 0.79
Evaluation of anthropogenic dose distribution amongst building walls at the Metlino area of the upper Techa River region. Radiat Environ Biophys (2008) 0.78
External dose reconstruction for the former village of Metlino (Techa River, Russia) based on environmental surveys, luminescence measurements, and radiation transport modelling. Radiat Environ Biophys (2017) 0.75
Risk quantification. Radiat Environ Biophys (2003) 0.75
Dose reconstruction system for the exposed population living along the Techa River. Health Phys (2000) 1.19
Simple model for the reconstruction of radionuclide concentrations and radiation exposures along the Techa River. Health Phys (1999) 1.19
Review of historical monitoring data on Techa River contamination. Health Phys (1999) 1.03
Investigations of thermoluminescence dosimetry in the Techa river flood plain: analysis of the new results. Radiat Prot Dosimetry (2002) 0.99
Issues in the reconstruction of environmental doses on the basis of thermoluminescence measurements in the Techa riverside. Health Phys (1998) 0.98
Depth-dose distribution in bricks determined by thermoluminescence and by Monte-Carlo calculation for external gamma-dose reconstruction. Appl Radiat Isot (1996) 0.96
First international intercomparison of luminescence techniques using samples from the Techa River Valley. Health Phys (2002) 0.95
Preliminary uncertainty analysis for the doses estimated using the Techa River dosimetry system--2000. Health Phys (2001) 0.91
Nicotine metabolism and intake in black and white smokers. JAMA (1998) 5.03
Smokers of low-yield cigarettes do not consume less nicotine. N Engl J Med (1983) 4.80
Improved gas chromatographic method for the determination of nicotine and cotinine in biologic fluids. J Chromatogr (1981) 3.72
Cotinine disposition and effects. Clin Pharmacol Ther (1983) 3.26
Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum. Clin Pharmacol Ther (1988) 3.05
Influence of smoking fewer cigarettes on exposure to tar, nicotine, and carbon monoxide. N Engl J Med (1986) 2.87
Daily intake of nicotine during cigarette smoking. Clin Pharmacol Ther (1984) 2.43
Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin Pharmacol Ther (1994) 2.41
Dose-responses from multi-model inference for the non-cancer disease mortality of atomic bomb survivors. Radiat Environ Biophys (2012) 2.31
Nicotine and cotinine elimination pharmacokinetics in smokers and nonsmokers. Clin Pharmacol Ther (1993) 2.30
Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J Pharmacol Exp Ther (1994) 2.28
Protracted radiation exposure and cancer mortality in the Techa River Cohort. Radiat Res (2005) 2.16
Cotinine in the serum, saliva, and urine of nonsmokers, passive smokers, and active smokers. Am J Public Health (1988) 2.16
The correlation of age of onset with CTG trinucleotide repeat amplification in myotonic dystrophy. J Med Genet (1992) 2.15
Ethnic differences in N-glucuronidation of nicotine and cotinine. J Pharmacol Exp Ther (1999) 2.14
Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. J Pharmacol Exp Ther (1982) 2.12
Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines. Eur J Pharmacol (1999) 1.73
Prospective multicenter evaluation of colon capsule examination indicated by colonoscopy failure or anesthesia contraindication. Endoscopy (2012) 1.63
Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/benzoylecgonine concentrations. J Clin Psychopharmacol (1993) 1.60
Circadian blood nicotine concentrations during cigarette smoking. Clin Pharmacol Ther (1982) 1.60
Preliminary observations on the effects of age on oropharyngeal deglutition. Dysphagia (1989) 1.53
Adequacy of "hot biopsy" for the treatment of diminutive polyps: a prospective randomized trial. Am J Gastroenterol (1989) 1.49
Dapsone, trimethoprim, and sulfamethoxazole plasma levels during treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome (AIDS). Evidence of drug interactions. Ann Intern Med (1989) 1.48
Reduced tar, nicotine, and carbon monoxide exposure while smoking ultralow- but not low-yield cigarettes. JAMA (1986) 1.45
Determinants of nicotine intake while chewing nicotine polacrilex gum. Clin Pharmacol Ther (1987) 1.45
Deficient C-oxidation of nicotine. Clin Pharmacol Ther (1995) 1.43
Thyroid cancer risk in areas of Ukraine and Belarus affected by the Chernobyl accident. Radiat Res (2006) 1.35
Methamphetamine and ethanol interactions in humans. Clin Pharmacol Ther (1995) 1.28
Nicotine metabolism and elimination kinetics in newborns. Clin Pharmacol Ther (2000) 1.26
A reordering of human chromosome 19 long-arm DNA markers and identification of markers flanking the myotonic dystrophy locus. Genomics (1989) 1.24
Bioavailability of sublingual buprenorphine. J Clin Pharmacol (1997) 1.21
Post-Chornobyl thyroid cancers in Ukraine. Report 1: estimation of thyroid doses. Radiat Res (2005) 1.20
Dose reconstruction system for the exposed population living along the Techa River. Health Phys (2000) 1.19
Simple model for the reconstruction of radionuclide concentrations and radiation exposures along the Techa River. Health Phys (1999) 1.19
Trans-3'-hydroxycotinine: disposition kinetics, effects and plasma levels during cigarette smoking. Br J Clin Pharmacol (2001) 1.17
Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking. Br J Clin Pharmacol (1997) 1.17
Effects of cigarette smoking and its cessation on lipid metabolism and energy expenditure in heavy smokers. J Clin Invest (1994) 1.16
Internal exposure from the ingestion of foods contaminated by 137Cs after the Chernobyl accident--report 2. Ingestion doses of the rural population of Ukraine up to 12 y after the accident (1986-1997). Health Phys (2000) 1.14
Daily use of smokeless tobacco: systemic effects. Ann Intern Med (1989) 1.13
Influence of nicotine on cardiovascular and hormonal effects of cigarette smoking. Clin Pharmacol Ther (1984) 1.11
Comparison of EPR occupational lifetime external dose assessments for Mayak nuclear workers and film badge dose data. Radiat Environ Biophys (2006) 1.11
Nicotine and carbon monoxide intake from high- and low-yield cigarettes. Clin Pharmacol Ther (1984) 1.10
Suppression of nicotine intake during ad libitum cigarette smoking by high-dose transdermal nicotine. J Pharmacol Exp Ther (1998) 1.10
Incidence of Guillain-Barré syndrome in Ontario and Quebec, 1983-1989, using hospital service databases. Epidemiology (1994) 1.10
Stable isotope studies of nicotine kinetics and bioavailability. Clin Pharmacol Ther (1991) 1.09
Development of an improved dose reconstruction system for the Techa River population affected by the operation of the Mayak Production Association. Radiat Res (2006) 1.07
Time trends of thyroid cancer incidence in Belarus after the Chernobyl accident. Radiat Res (1999) 1.06
Radiation doses from Ural region. Nature (1996) 1.06
Disposition kinetics and effects of intravenous nicotine. Clin Pharmacol Ther (1980) 1.06
Nicotine dependence and tolerance in man: pharmacokinetic and pharmacodynamic investigations. Prog Brain Res (1989) 1.06
Visual cognition: a new look at the two-visual systems model. Neuropsychologia (2005) 1.05
Intravenous nicotine replacement suppresses nicotine intake from cigarette smoking. J Pharmacol Exp Ther (1990) 1.04
Review of historical monitoring data on Techa River contamination. Health Phys (1999) 1.03
Disposition kinetics and effects of menthol. Clin Pharmacol Ther (1999) 1.03
Metabolism of nicotine by human liver microsomes: stereoselective formation of trans-nicotine N'-oxide. Chem Res Toxicol (1992) 1.03
Solid cancer mortality in the techa river cohort (1950-2007). Radiat Res (2013) 1.03
Studies on the Techa river populations: dosimetry. Radiat Environ Biophys (2002) 1.02
Blood cotinine levels as indicators of smoking treatment outcome. Clin Pharmacol Ther (1984) 1.02
Effects of cigarette smoking and carbon monoxide on nicotine and cotinine metabolism. Clin Pharmacol Ther (2000) 1.01
Reevaluation of waterborne releases of radioactive materials from the Mayak Production Association into the Techa River in 1949-1951. Health Phys (2012) 1.01
Sympathomimetic effects of paraxanthine and caffeine in humans. Clin Pharmacol Ther (1995) 0.99
Investigations of thermoluminescence dosimetry in the Techa river flood plain: analysis of the new results. Radiat Prot Dosimetry (2002) 0.99
Issues in the reconstruction of environmental doses on the basis of thermoluminescence measurements in the Techa riverside. Health Phys (1998) 0.98
Releasable suture technique for trabeculectomy. Indian J Ophthalmol (1997) 0.98
Important factors governing exposure of the population and countermeasure application in rural settlements of the Russian Federation in the long-term after the Chernobyl accident. J Environ Radioact (2001) 0.97
On an evaluation of external dose values in the Techa River Dosimetry System (TRDS) 2000. Radiat Environ Biophys (2003) 0.97
Cardiovascular effects of carbon monoxide and cigarette smoking. J Am Coll Cardiol (2001) 0.97
Mechanistic modelling in large case-control studies of lung cancer risk from smoking. Stat Med (2002) 0.96
Decrease in the size of the myotonic dystrophy CTG repeat during transmission from parent to child: implications for genetic counselling and genetic anticipation. Am J Med Genet (1993) 0.96
Depth-dose distribution in bricks determined by thermoluminescence and by Monte-Carlo calculation for external gamma-dose reconstruction. Appl Radiat Isot (1996) 0.96
The Techa River dosimetry system: methods for the reconstruction of internal dose. Health Phys (2000) 0.96
Dose-related cardiovascular and endocrine effects of transdermal nicotine. Clin Pharmacol Ther (1998) 0.96
Studies on the Mayak nuclear workers: dosimetry. Radiat Environ Biophys (2002) 0.95
Reconstruction of long-lived radionuclide intakes for Techa riverside residents: 137Cs. Health Phys (2013) 0.95
First international intercomparison of luminescence techniques using samples from the Techa River Valley. Health Phys (2002) 0.95
Reconstruction of the contamination of the Techa River in 1949-1951 as a result of releases from the "Mayak" Production Association. Radiat Environ Biophys (2012) 0.95
Ophthalmoplegic migraine: inflammatory neuropathy with secondary migraine? Can J Neurol Sci (2007) 0.95
Miller-Dieker syndrome. Detection of a cryptic chromosome translocation using in situ hybridization in a family with multiple affected offspring. Am J Dis Child (1993) 0.94
Nicotine renal excretion rate influences nicotine intake during cigarette smoking. J Pharmacol Exp Ther (1985) 0.94
Reconstruction of long-lived radionuclide intakes for Techa riverside residents: strontium-90. Health Phys (2011) 0.94
Breast cancer risk in atomic bomb survivors from multi-model inference with incidence data 1958-1998. Radiat Environ Biophys (2011) 0.94
Photon dose conversion coefficients for human teeth in standard irradiation geometries. Health Phys (2005) 0.94
Thyroid cancer risk to children calculated. Nature (1998) 0.93